Hikma Pharmaceuticals (LSE:HIK) Pre-Tax Income : £222 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Hikma Pharmaceuticals's pretax income for the six months ended in Dec. 2023 was £62 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was £222 Mil. Hikma Pharmaceuticals's pretax margin was 5.46%.

During the past 13 years, Hikma Pharmaceuticals's highest Pretax Margin was 24.31%. The lowest was -38.12%. And the median was 17.73%.

Hikma Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Hikma Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Pre-Tax Income Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

374.63

415.15

409.09

191.29

221.99

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															169.20	174.58	14.78	159.98	62.41

Competitive Comparison of Hikma Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hikma Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's Pre-Tax Income falls into.

Hikma Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Hikma Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	477.16	+	0	+	-57.67	+	5.53	+	-203.03
	=	222

Hikma Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	229.89	+	0	+	-21.33	+	3.16	+	-149.31
	=	62

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £222 Mil.

Hikma Pharmaceuticals (LSE:HIK) Pre-Tax Income Explanation

Hikma Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	62.41	/	1143.92
	=	5.46%

During the past 13 years, Hikma Pharmaceuticals's highest Pretax Margin was 24.31%. The lowest was -38.12%. And the median was 17.73%.

Hikma Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (LSE:HIK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines